FENC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 38 cases where FENC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 82%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 65 cases where FENC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for FENC just turned positive on October 20, 2026. Looking at past instances where FENC's MACD turned positive, the stock continued to rise in 37 of 48 cases over the following month. The odds of a continued upward trend are 77%.
Following a +4.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where FENC advanced for three days, in 204 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FENC as a result. In 92 of 113 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The 10-day moving average for FENC crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FENC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for FENC entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.527) is normal, around the industry mean (2.973). FENC has a moderately low P/E Ratio (-86.000) as compared to the industry average of (-1.705). Projected Growth (PEG Ratio) (0.100) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (5.963) is also within normal values, averaging (438.009).
The Tickeron Seasonality Score of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. FENC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 46 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FENC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Moving Average Convergence Divergence (MACD) for SEPN turned positive on October 20, 2026. Looking at past instances where SEPN's MACD turned positive, the stock continued to rise in 9 of 10 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on SEPN as a result. In 25 of 28 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.
SEPN moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where SEPN advanced for three days, in 87 of 98 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for SEPN crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SEPN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
SEPN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SEPN entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.934) is normal, around the industry mean (2.973). SEPN has a moderately low P/E Ratio (-77.132) as compared to the industry average of (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (17.361) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. SEPN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SEPN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
FENC | ||
|---|---|---|
OUTLOOK RATING 1..100 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 90 | |
SMR RATING 1..100 | 95 | |
PRICE GROWTH RATING 1..100 | 42 | |
P/E GROWTH RATING 1..100 | 46 | |
SEASONALITY SCORE 1..100 | 21 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| FENC | SEPN | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 81% | 1 day ago 89% |
| MACD ODDS (%) | 1 day ago 77% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 86% |
| Advances ODDS (%) | 3 days ago 74% | 1 day ago 89% |
| Declines ODDS (%) | 1 day ago 82% | 9 days ago 71% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 85% | 1 day ago 73% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FENC’s FA Score shows that 1 FA rating(s) are green while SEPN’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FENC’s TA Score shows that 5 TA indicator(s) are bullish while SEPN’s TA Score has 4 bullish TA indicator(s).
FENC (@Biotechnology) experienced а +4.01% price change this week, while SEPN (@Biotechnology) price change was +12.22% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
FENC is expected to report earnings on Nov 12, 2026.
SEPN is expected to report earnings on Nov 09, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, FENC has been loosely correlated with AMLX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then AMLX could also see price increases.
| Ticker / NAME | Correlation To FENC | 1D Price Change % | ||
|---|---|---|---|---|
| FENC | 100% | -0.58% | ||
| AMLX - FENC | 37% Loosely correlated | -1.58% | ||
| RZLT - FENC | 37% Loosely correlated | +4.32% | ||
| COYA - FENC | 36% Loosely correlated | N/A | ||
| REPL - FENC | 35% Loosely correlated | +2.30% | ||
| SEPN - FENC | 34% Loosely correlated | +0.29% | ||
More | ||||
A.I.dvisor indicates that over the last year, SEPN has been loosely correlated with SRRK. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SEPN jumps, then SRRK could also see price increases.
| Ticker / NAME | Correlation To SEPN | 1D Price Change % | ||
|---|---|---|---|---|
| SEPN | 100% | +0.29% | ||
| SRRK - SEPN | 41% Loosely correlated | -2.42% | ||
| KURA - SEPN | 40% Loosely correlated | -0.20% | ||
| RYTM - SEPN | 39% Loosely correlated | +2.57% | ||
| TSHA - SEPN | 38% Loosely correlated | -2.79% | ||
| IMNM - SEPN | 37% Loosely correlated | +1.44% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LITZ | 34.60 | 6.62 | +23.66% |
| Tradr 2X Short LITE Daily ETF (LITZ) | |||
| TMFE | 31.16 | -0.02 | -0.06% |
| Motley Fool Capital Efficiency 100 Index ETF (TMFE) | |||
| PFIX | 57.00 | -1.87 | -3.18% |
| Simplify Interest Rate Hedge ETF (PFIX) | |||
| BETH.X | 2380.452000 | -88.977050 | -3.60% |
| Beacon ETH cryptocurrency | |||
| MASK.X | 0.423390 | -0.018835 | -4.26% |
| Mask Network cryptocurrency | |||